Skip to main content
Erschienen in: Obesity Surgery 6/2023

Open Access 06.04.2023 | Review

One Anastomosis Gastric Bypass (OAGB) with a 150-cm Biliopancreatic Limb (BPL) Versus a 200-cm BPL, a Systematic Review and Meta-analysis

verfasst von: Mohamed AbdAlla Salman, Ahmed Salman, Mohamed Moustafa Assal, Mohammed Elsherbiney, Mohamed Tourky, Ahmed Elewa, Adel Mohamed Khalaf, Mohamed A. Gadallah, Mahmoud Gebril, Sadaf Khalid, Hossam Shaaban, Aboalgasim Alamin Mohammed, Mohamed Hosny Abdo Osman, Haitham Hassan

Erschienen in: Obesity Surgery | Ausgabe 6/2023

Abstract

This is a systematic review and meta-analysis that assessed the impact of performing OAGB with a 150-cm BPL versus a 200-cm BPL concerning weight loss, comorbidities remission, and adverse nutritional effects. The analysis included studies that compared patients who underwent OAGB with a 150-cm BPL and 200-cm BPL. Eight studies were eligible for this review after searching in the EMBASE, PubMed central database, and Google scholar. The pooled analysis revealed favoring the 200-cm BPL limb length for weight loss, with a highly significant difference in the TWL% (p=0.009). Both groups showed comparable comorbidities remission. Significantly higher ferritin and folate deficiency rates were found in the 200-cm BPL group. Considering a 200-cm BPL when performing OAGB delivers a better weight loss outcome than a 150-cm BPL, which is at the expense of a more severe nutritional deficiency. No significant differences were found regarding the comorbidities’ remission.
Hinweise

Key Points:

(1) Obesity has been a pandemic with a continuously rising prevalence all over the world.
(2) One anastomosis gastric bypass (OAGB) is one of the most widely accepted bariatric surgery procedures owing to its simplicity and proposed efficacy and safety.
(3) Up till now, no optimal biliopancreatic limb (BPL) length has been standardized in the OAGB operation.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Obesity has been a pandemic with a continuously rising prevalence all over the world [1]. The only certain solution for severe obesity and its associated comorbidities in patients who are unable to lose weight through lifestyle modification and non-surgical means is bariatric surgery [2].
One anastomosis gastric bypass (OAGB) is one of the most widely accepted bariatric surgery procedures owing to its simplicity and proposed efficacy and safety [3, 4]. Currently, it comes just after sleeve gastrectomy and Roux-en-Y gastric bypass surgery (RYGB) [5]. OAGB comprises the creation of a long narrow gastric tube that undergoes side-to-side or end-to-side gastrojejunostomy. This anastomosis is formed at approximately150- to 200-cm distal to the Treitz ligament [6].
It has been claimed that OAGB is advantaged by its simplicity and the easiness of revision and reversion in addition to the fewer potential sites for internal hernia or leakage [7].
Up until now, no optimal biliopancreatic limb (BPL) length has been standardized in the OAGB operation. An improperly long BPL can elevate the risk of postoperative excessive loss of weight and developing nutritional deficiencies [8]. There is considerable variation in the BPL length customized by bariatric surgeons during OAGB [9]. Different BPL lengths have been studied to achieve a satisfactory weight loss with the least risk as far as possible [10]. Although a constant BPL length of 200 cm was the most commonly used [11], it has been presumed that a BPL length of 150 cm is the ideal [12].
This systematic review and meta-analysis aimed to assess the impact of performing OAGB with a 150-cm BPL versus a 200-cm BPL in terms of weight loss, comorbidities remission, and adverse nutritional effects.

Methods

Study Design

This is a systematic review and meta-analysis that was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [13]. This analysis included studies that compared patients who underwent OAGB with a BPL length of 150 cm and those who had a BPL length of 200 cm. The search was performed using electronic resources: the EMBASE, PubMed central database, and Google scholar.

Selection Strategy and Criteria

The search was conducted with restriction of results to original articles published until the time of analysis. The search was performed using the medical subject headings (MeSH) terms: “one anastomosis gastric bypass” OR “one-anastomosis gastric bypass” OR “single anastomosis gastric bypass” OR “single-anastomosis gastric bypass” OR “mini gastric bypass” OR “mini-gastric bypass” AND “biliopancreatic limb length” OR “bilio-pancreatic limb length” OR “BPL length” OR “BP limb length” AND “effect” OR “impact” OR “difference” OR “outcome” OR “risks” OR “benefits” OR “advantages” AND “150 cm” AND “200 cm.”
The search was performed by two independent reviewers (the first and second authors). Then, articles were matched and screened to ensure eligibility.
  • Inclusion Criteria
Original articles available in English, those are addressing the effect of different BPL lengths in patients undergoing OAGB.
  • Exclusion Criteria
Reviews, commentaries, and general discussion papers that do not present original data were excluded. Studies that do not contain a comparison between BPL lengths of 150 cm and 200 cm were also excluded.

Data Extraction, Collection, and Analysis

The included articles were carefully read and the relevant data were extracted, registered, and analyzed. The included studies were evaluated for the encountered bias using the “Cochrane Collaboration”s tool for assessing the risk of bias.”

Summary Measures

The primary outcome was the difference between 200-cm BPL and 150-cm BPL when performing OAGB, in the impact on weight loss outcome. The secondary outcome was the differences in comorbidities remission and nutritional deficiency rates.

Statistical Analysis

The retrieved data were presented, analyzed, and tabulated. The meta-analysis and assessment of bias were performed using the Review Manager Software (RevMan version 5.4, the Cochrane Collaboration, London, UK). Numerical data were compared with the mean differences in effects between both groups, which were pooled into weighted mean differences (WMDs). Categorical data were presented as odds ratios and 95% confidence intervals (CIs). The percentage of variance in the meta-analysis was indicated by the I2 statistic to assess the heterogeneity between studies. Fixed- and random-effect models were used accordingly.

Results

The initial research on the electronic resources yielded 2026 records. After adjusting the duplications, the search provided 1199 results. The articles’ titles and abstracts were checked and 1183 articles were excluded. Reading the full texts of the remaining 16 articles resulted in the inclusion of 7 articles. One study was available as a poster abstract only [14]. However, considering the published data, the poster was included in the review. Thus, finally, 8 studies were eligible for this systematic review [9, 1420]. Figure 1 demonstrates the included studies flow chart. One of the included articles [18] was an additional report of a previously published study [16]. Therefore, we omitted the repeated data and kept those concerning different outcomes.
The included articles were all recent. They were published from 2019 to 2022. The populations were patients scheduled for OAGB. They underwent mean follow-up periods ranging from 10 to 44.87 months. However, in most of the studies, the median follow-up period was 24 months [9, 1517, 19]. The sample size of the included studies ranged from 155 [19] to 784 [20]. All the included studies were retrospective analyses for prospectively registered hospitals databases.
Five out of the sex included studies categorized their cohort into two groups: 200-cm BPL group and 150-cm BPL group. In the 3 other studies, there was an additional group: a 180-cm BPL group [9, 17] and a 250-cm BPL group [19].
The total population number of the studies included in the current review was 2599: 1100 (42.3%) underwent OAGB with a 150-cm BPL and 1336 (51.4%) underwent OAGB with a 200-cm BPL. The remaining 111 patients (4.3%) underwent OAGB with variable BPL lengths and were not included in the analysis.
The characteristics of the included studies and the differences between the 200-cm BPL and 150-cm BPL groups in the weight loss, comorbidities remission, and nutritional state are shown in Tables 1 and 2.
Table 1
The included studies and patients characteristics
Study
Boyle and Mahawar [15]
Omar et al. [16]
Pizza et al. [17]
Jedamzic et al. [19]
Slagter et al. [9]
Sam et al. [18]
Samuel et al. [14]
Bertrand et al. [20]
Year
2020
2021
2020
2020
2021
2022
2019
 
Type of study
Retrospective analysis of the prospective hospital database
Follow-up (months)
24
24
24
24
24
36
12
32.4–44.87
150-cm group (n)
118
171
60
11
172
171
178
392
200-cm group (n)
225
234
60
93
72
234
310
392
Both groups (n)
343
405
180
155
244
405
488
784
Females: n (%)
232 (67.6)
275 (67.9)
117 (65%)
111 (71.6)
199 (81.6)
275 (67.9)
327 (67)
598 (76.3)
Mean age
46.3±12.8
46 ± 10.98
35.2 ± 9
45 ± 4.5
48 ± 11
46 ± 10.98
46.5±7.25
44±11.3
Baseline weight
137.6
139±29.96
119.9±28.9
128.5 (92–196)
124±17
139±29.96
NA
121±16, 120±16.6
Baseline BMI
48.39
49±8.14
44.93±7.56
45.1 (33.1–71.1)
44±4
49±8.14
44±2.75
43±3.6, 42.6±3.6
200-cm group EWL%
75± 20.1
NA
61.2 ± 12.1
82.2 ± 24.8
75 (59–81)
76.46±20.1
68 (53–83)
76.8 ± 21.6
150-EWL% mean
74± 22
NA
60.7 ± 16.1
63.2 ±17.0
83 (65–99)
75.02+21.35
67 (53–80)
75.5 ± 24.02
200-TWL% mean
36.1 ± 9.2
NA
41.8 ± 8.9
34.5 ± 9.4
34 (28–38)
36.15±9.19
NA
NA
150-TWL% mean
34 ± 9.8
NA
40.7 ± 9.4
33.1 ± 5.2
29 (23–36)
34.12+9.49
NA
NA
Diabetes mellitus resolution: n (%)
 200-cm group
29 (46)
NA
5 (50)
NA
13 (87)
NA
NA
45 (48.4)
 150-cm group
12 (46.2)
NA
5 (45.5)
NA
21 (68)
NA
NA
38 (50.7)
Diabetes mellitus improvement: n (%)
 200-cm group
24 (38)
NA
3 (30)
NA
2 (13)
NA
NA
NA
 150-cm group
13 (50)
NA
2 (18.2)
NA
10 (32)
NA
NA
NA
Hypertension resolution: n (%)
 200-cm group
28 (33.7)
NA
17 (53.1)
NA
10 (48)
NA
NA
33 (21.9)
 150-cm group
21 (42.9)
NA
18 (52.9)
NA
28 (49)
NA
NA
31 (22.3)
Hypertension improvement: n (%)
 200-cm group
24 (28.9)
NA
NA
NA
11 (52)
NA
NA
NA
 150-cm group
11 (22.4)
NA
NA
NA
25 (42)
NA
NA
NA
Reoperation: n (%)
 200-cm group
2 (0.89)
NA
1 (1.67)
NA
NA
NA
NA
31 (7.9)
 150-cm group
0 (0)
NA
2 (3.33)
NA
NA
NA
NA
16 (4.1)
Table 2
Comparison between both groups in the nutrients deficiency rates
Authors
Boyle and Mahawar [15]
Omar et al. [16]
Pizza et al. [17]
Jedamzic et al. [19]
Slagter et al. [9]
Sam et al. [18]
Samuel et al. [14]
Bertrand et al. [20]
Low serum protein: n (%)
 200-cm group
NA
NA
5 (59.6)
23 (38.3)
NA
NA
NA
NA
 150-cm group
NA
NA
3 (5.7)
2 (28.6)
NA
NA
NA
NA
Low serum albumin: n (%)
 200-cm group
2 (0.92)
3 (2.53)
5 (3.8)
2 (3.3)
NA
3 (2.53)
NA
25 (6.4)
 150-cm group
2 (1.8)
4 (2.29)
2 (1.9)
2 (2.9)
NA
4 (2.29)
NA
9 (2.3)
Low serum ferritin: n (%)
 200-cm group
NA
18 (14.75)
4 (21.1)
19 (33.9)
NA
NA
NA
65 (16.6)
 150-cm group
NA
14 (11.97)
7 (13.4)
1 (14.3)
NA
NA
NA
38 (9.7)
Low serum folate: n (%)
 200-cm group
NA
18 (13.24)
NA
2(3.6)
NA
NA
NA
24 (6.1)
 150-cm group
NA
11 (9.6)
NA
0 (0)
NA
NA
NA
12 (3.1)
Low serum vitamin B12: n (%)
 200-cm group
NA
1 (0.71)
4 (7.6)
1 (1.7)
NA
NA
NA
27 (6.9)
 150-cm group
NA
0 (0)
3 (5.7)
0 (0)
NA
NA
NA
26 (6.6)
High serum parathyroid hormone: n (%)
 200-cm group
NA
64 (46.38)
NA
15 (26.3)
NA
NA
NA
NA
 150-cm group
NA
45 (40.91)
NA
3 (42.9)
NA
NA
NA
NA
Low serum vitamin D: n (%)
 200-cm group
NA
6 (4.41)
7 (13.4)
45 (76.3)
NA
NA
NA
NA
 150-cm group
NA
4 (3.57)
6 (11.5)
6 (85.7)
NA
NA
NA
NA
Regarding studies outcomes, these were mainly the effect of different BPL lengths on weight loss and comorbidities resolution [9, 14, 15, 17, 20]. Other outcomes were the effect on haematinics [16], micronutrients [16, 17, 19] and liver function tests [18].
In all studies, the basic preoperative weight, comorbidities, and nutritional status were comparable in the study groups.
The pooled analysis revealed favoring the 200-cm BPL limb length for weight loss, with a statistically non-significant difference in the EWL% (p=0.67) and a highly significant difference in the TWL% (p=0.009) (Fig. 2).
No statistically significant differences were found between the two groups in the percentages of diabetes mellitus resolution (p=0.78) or improvement (p=0.2). Likewise, no statistically significant differences were noted in hypertension resolution (p=0.54) or improvement (p=0.24) percentages (Fig. 3).
There was statistically significant difference between the two groups in the postoperative ferritin (p=0.002) and folate (p=0.04) deficiency. Otherwise, no statistically significant differences was found between the two groups in the abnormal levels of any of the other studied nutrients. These findings were obtained from pooled analyses of 2 to 5 studies. The studied nutrients were albumin [9, 16, 17, 19, 20], total protein [17, 19], ferritin [16, 17, 19, 20] (Fig. 4), vitamin B12 [16, 17, 19, 20], folate [16, 19, 20], vitamin D [16, 17, 19] and parathyroid hormone [16, 19] (Fig. 5).
The reoperation rates were described in 4 studies [9, 15, 17, 20] (Fig. 6), their meta-analysis revealed non-significant difference between the two groups (p=0.13).
The critical assessment graph and summary of the risks of bias within each study, as thought by the authors, are shown in Fig. 7.

Summary of the Included Studies

Boyle and Mahawar compared weight loss outcomes, comorbidities remission, hemoglobin and albumin levels, and morbidity/mortality of 118 patients undergoing OAGB with a 150-cm BPL with 225 patients with a 200-cm BPL. They found that both groups showed similar outcomes and concluded that a BPL of 150 cm is not inferior to that of 200 cm.
The study of Omar et al. [16] estimated the nutritional status of 234 patients with OAGB-200 cm and 171 with OAGB-150 cm. They found that micronutrients deficiency (vitamins A, B12, D, and E, folate, albumin, parathyroid hormone, and ferritin) occurred in both groups, with a higher incidence in the 200-cm group.
Pizza et al. [17] assessed the difference between both lengths in the weight loss outcome, comorbidities remission, nutritional status, and gastroesophageal reflux disease. They evaluated 180 patients distributed equally among 150-cm, 180-cm, and 200-cm groups. They did not note significant differences in any of the studied parameters apart from ferritin deficiency rates, which differed significantly between the 150-cm and 200-cm groups.
Sam et al. [18] studied the effect of both lengths on hepatic functions derangement. They explored the OAGB safety in terms of its effect on liver functions, with no significant difference between both limb lengths.
Slagter et al. [9] evaluated three BPL lengths groups (150-cm, 180-cm, and 200-cm) concerning differences in the weight loss outcome. Their published figures display higher TWL% in 200-cm BPL patients. Nevertheless, longer BPL did not deliver higher comorbidities remission rates.
Jedamzik et al. [19] evaluated the impact of BPL length in OAGB on protein and micronutrients deficiency. They assessed patients with 150-, 200-, and 250-cm BPL lengths. They reported that systemic levels of vitamins (A, B12, D, and E), folate, albumin, parathyroid hormone, calcium, iron, ferritin, and magnesium were comparable in patients with 150-cm and 200-cm BPL lengths. In patients with 250-cm BPL length, folate level was significantly lower when compared to patients with other limb lengths (150 and 200 cm).
In their published poster, Samuel et al. [14] compared weight loss in patients undergoing OAGB with a 150 cm to those with a 200-cm BPL. No significant differences in BMI, diabetes mellitus, hypertension, obstructive sleep apnea, or gastroesophageal reflux disease improvement were found.
Bertrand et al. [20], in their single-center retrospective study of 784 patients, compared patients who underwent OAGB with a 200-cm BPL to patients with OAGB with a 150-cm BPL in terms of weight loss and late morbidity. They used propensity score matching method to match patients in 1:1 ration based on age, sex, and BMI. They found no significant difference in the early morbidity. Regarding nutritional deficiencies, the 150-cm group showed a significantly lower percentage of hypoalbuminemia, low vitamin B9, and low ferritin. There was no significant difference in the EWL%.

Discussion

For long-term treatment of obesity, procedures including malabsorption with restriction are likely superior to those restrictive only [21]. OAGB is one of the procedures combining malabsorption with restriction. Hence, it has gained acceptance for the treatment of obesity and its associated comorbidities. The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has recently acknowledged it as a mainstream bariatric surgery procedure [22]. Unfortunately, there is still no standardized technique to perform OAGB, with the length of BPL being the main debating item. Actually, there has been strong controversy considering different BPL lengths [23].
Despite using different BPL lengths by surgeons, a length of 200 cm has been the most commonly used [11, 2426]. It was adopted by Rutledge [27] who first introduced the OAGB technique. Notwithstanding, several studies advocate for a 150-cm BPL to minimize the nutritional deficiencies with keeping an acceptable weight loss and comorbidities remission [2832].
Only one meta-analysis could be reached in this context. Tasdighi et al. [33] performed a comparison between < 200-cm and ≥ 200-cm BPL lengths. However, in view that the latest IFSO Consensus Conference has recommended a BPL of 200 cm or less for OAGB to achieve a balance between effectiveness and safety, the current review was an attempt to evaluate which of the IFSO recommended lengths would be better.
The present work, to our knowledge, is the first meta-analysis comparing OAGB using a 200-cm BPL to a 150-cm BPL.
This review found that 200-cm BPL displayed better weight loss outcomes with a significant difference in the TWL%. There was comparable comorbidities remission. Nutritional deficiency rates were higher in patients with a 200-cm BPL.
The cause of the TWL% significant difference between the two groups is that all included studies showed higher TWL% in patients with 200-cm BPL [9, 15, 1719]. Moreover, one of the included large-sized studies (n=244) [9] showed a high median difference (34 in 200-cm BPL group vs. 29 in 150-cm BPL group).
The mechanisms underlying superior weight loss outcomes with longer BPL are still indistinct. A longer BPL leads to bypassing larger area of the jejunum, with subsequent early nutrients malabsorption, leading to more loss of weight [34].
The included studies were unanimous concerning the comparable comorbidities remission effect of both limb lengths [9, 15, 17, 20]. This is explaining the overall non-significant difference found in this review. The overall hypertension remission (complete resolution or improvement) was encountered in 79.6% of patients with 150-cm BPL and 74.1% of patients with 200-cm length. This rate is in harmony with previous reports [7, 35, 36]. Bariatric surgery associated glycemic control has been extensively documented. The overall diabetes mellitus remission was found to occur in 92.6% of patients with 150-cm BPL compared to 86.4% in patients with 200-cm length. This rate aligns with Buchwald et al. [37] meta-analysis, who reported a ≥ 80% diabetes mellitus remission rate after OAGB. The 150-cm BPL-related higher remission rates may be attributed to that diabetes mellitus remission is prompted by several factors, such as age, baseline BMI and HBA1c levels, disease duration, and type of medications [33]. These factors are difficult to be adjusted for a reliable comparison.
The significantly higher ferritin and folate deficiency in the 200-cm BPL group denotes the higher malabsorption impact related to the longer BPL. The lack of significance in other nutrients’ deficiency in this analysis is likely due to the fact that all studies that assessed the nutritional state showed deficiency in both groups, either preoperatively, as a consequence of obesity-related nutritional disorders, or postoperatively, as operative sequels.
It is believed that OAGB owns a significant malabsorptive element since it somewhat acts as a biliopancreatic diversion, with a lack of the potentiality for digestion and absorption as food does not contact with the bypassed small bowel at all [38]. Interestingly, the randomized controlled trial introduced by Robert et al. [39] compared the outcomes of OAGB with a BPL of 200 cm versus standard Roux-en-Y gastric bypass (RYGB) with a BPL of 150 cm. They found that OAGB was related to weight loss and metabolic improvement comparable to that of RYGB, with higher incidences of malabsorption and nutritional adverse events. Similarly, Carbajo et al. [40] studied 1200 patients who were submitted to laparoscopic OAGB. The authors individualized the BPL length that ranged from about 200 cm up to 350 cm according the patient’s small bowel length and the BMI (tailoring technique). Nevertheless, only 1.1% of the patients suffered malnutrition. This was explained by the strict postoperative regimen followed by the investigators. In their malnutrition cases, the condition was temporary and responded to a strict program of enteral supplementation and counseling.
The current analysis reveals that the 200-cm BPL lengths had a superior weight loss outcome, namely the percentage of total weight loss, yet with a more severe nutritional deficiency. The lower weight loss outcome attributed to a 150-cm BPL is clinically questionable, with a mean TWL% difference of 2.6% and a mean EWL% of 0.9%. However, our findings imply the proper selection of compliant patients and the implementation of a strict surveillance program if the patients will undergo OAGB with a 200-cm BPL.
Some shortcomings should be acknowledged in the current systematic review including the small number of included studies, which is justified by the shortage of studies addressing this issue, and the lack of standardization of the follow-up period, where we tried our best to fix a follow-up period of 24 months to report the data whenever possible. In addition, all the included studies were retrospective analyses for a prospectively obtained hospital database. Unfortunately, no randomized controlled trials were available. Finally, we were obliged to include a poster abstract since it included valuable data regarding the weight loss outcome of a relatively large population number. Nevertheless, our study has the strength of being the first meta-analysis addressing these two limb lengths for more dedicated specification and standardization of the procedure technique within the IFSO recommendation window.

Conclusion

Considering a 200-cm BPL when performing OAGB delivers a better weight loss outcome than a 150-cm BPL, which is at the expense of a more severe nutritional deficiency. No significant differences were found regarding the comorbidities’ remission.

Declarations

Ethics Approval

For this type of study formal consent is not required.
Informed consent does not apply.

Conflict of Interest

The authors declare no conflict of interest
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

Literatur
1.
Zurück zum Zitat Agha M, Agha R. The rising prevalence of obesity: part A: impact on public health. Int J Surg Oncol (N Y). 2017;2(7):e17.CrossRefPubMed Agha M, Agha R. The rising prevalence of obesity: part A: impact on public health. Int J Surg Oncol (N Y). 2017;2(7):e17.CrossRefPubMed
3.
Zurück zum Zitat Noun R, Skaff J, Riachi E. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012;22:697–703.CrossRefPubMed Noun R, Skaff J, Riachi E. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012;22:697–703.CrossRefPubMed
4.
Zurück zum Zitat Lee WJ, Ser KH, Lee YC. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.CrossRefPubMed Lee WJ, Ser KH, Lee YC. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.CrossRefPubMed
5.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27:2279–89.CrossRefPubMedPubMedCentral Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27:2279–89.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ramos AC, Chevallier JM, Mahawar K, et al. IFSO Consensus Conference Contributors. IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) consensus conference statement on one-anastomosis gastric bypass (OAGB-MGB): results of a modified Delphi study. Obes Surg. 2020 May;30(5):1625–34.CrossRefPubMed Ramos AC, Chevallier JM, Mahawar K, et al. IFSO Consensus Conference Contributors. IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) consensus conference statement on one-anastomosis gastric bypass (OAGB-MGB): results of a modified Delphi study. Obes Surg. 2020 May;30(5):1625–34.CrossRefPubMed
7.
Zurück zum Zitat Victorzon M. Single-anastomosis gastric bypass: better, faster, and safer? Scand J Surg. 2015;104:48–53.CrossRefPubMed Victorzon M. Single-anastomosis gastric bypass: better, faster, and safer? Scand J Surg. 2015;104:48–53.CrossRefPubMed
8.
Zurück zum Zitat Komaei I, Sarra F, Lazzara C, et al. One anastomosis gastric bypass–mini gastric bypass with tailored biliopancreatic limb length formula relative to small bowel length: preliminary results. Obes Surg. 2019;29:3062–70.CrossRefPubMed Komaei I, Sarra F, Lazzara C, et al. One anastomosis gastric bypass–mini gastric bypass with tailored biliopancreatic limb length formula relative to small bowel length: preliminary results. Obes Surg. 2019;29:3062–70.CrossRefPubMed
9.
Zurück zum Zitat Slagter N, de Heide LJM, Jutte EH, et al. Outcomes of the one anastomosis gastric bypass with various biliopancreatic limb lengths: a retrospective single-center cohort study. Obes Surg. 2021;31(10):4236–42.CrossRefPubMedPubMedCentral Slagter N, de Heide LJM, Jutte EH, et al. Outcomes of the one anastomosis gastric bypass with various biliopancreatic limb lengths: a retrospective single-center cohort study. Obes Surg. 2021;31(10):4236–42.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Felsenreich DM, Langer FB, Eichelter J, et al. Bariatric surgery–how much malabsorption do we need?—a review of various limb lengths in different gastric bypass procedures. J Clin Med. 2021;10:674.CrossRefPubMedPubMedCentral Felsenreich DM, Langer FB, Eichelter J, et al. Bariatric surgery–how much malabsorption do we need?—a review of various limb lengths in different gastric bypass procedures. J Clin Med. 2021;10:674.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Mahawar KK, Kular KS, Parmar C, et al. Perioperative practices concerning one anastomosis (mini) gastric bypass: a survey of 210 surgeons. Obes Surg. 2018;28:204–11.CrossRefPubMed Mahawar KK, Kular KS, Parmar C, et al. Perioperative practices concerning one anastomosis (mini) gastric bypass: a survey of 210 surgeons. Obes Surg. 2018;28:204–11.CrossRefPubMed
12.
Zurück zum Zitat Mahawar K. One anastomosis gastric bypass is a “gastric bypass”. Obes Surg. 2016;26(11):2786–7.CrossRefPubMed Mahawar K. One anastomosis gastric bypass is a “gastric bypass”. Obes Surg. 2016;26(11):2786–7.CrossRefPubMed
13.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;21(339):b2700.CrossRef Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;21(339):b2700.CrossRef
14.
Zurück zum Zitat Samuel N, Hawkins H, Latimer J, et al. One-anastomosis gastric bypass: does bypass length matter? The Sunderland (UK) experience. Obes Surg. 2019;29(S5):652. Samuel N, Hawkins H, Latimer J, et al. One-anastomosis gastric bypass: does bypass length matter? The Sunderland (UK) experience. Obes Surg. 2019;29(S5):652.
15.
Zurück zum Zitat Boyle M, Mahawar K. One anastomosis gastric bypass performed with a 150-cm biliopancreatic limb delivers weight loss outcomes similar to those with a 200-cm biliopancreatic limb at 18-24 months. Obes Surg. 2020;30:1258–64.CrossRef Boyle M, Mahawar K. One anastomosis gastric bypass performed with a 150-cm biliopancreatic limb delivers weight loss outcomes similar to those with a 200-cm biliopancreatic limb at 18-24 months. Obes Surg. 2020;30:1258–64.CrossRef
16.
Zurück zum Zitat Omar I, Sam MA, Pegler ME, et al. Effect of one anastomosis gastric bypass on haematinics, vitamin D and parathyroid hormone levels: a comparison between 150 and 200 cm bilio-pancreatic limbs. Obes Surg. 2021;31:2954–61.CrossRefPubMed Omar I, Sam MA, Pegler ME, et al. Effect of one anastomosis gastric bypass on haematinics, vitamin D and parathyroid hormone levels: a comparison between 150 and 200 cm bilio-pancreatic limbs. Obes Surg. 2021;31:2954–61.CrossRefPubMed
17.
Zurück zum Zitat Pizza F, Lucido FS, D’Antonio D, et al. Biliopancreatic limb length in one anastomosis gastric bypass: which is the best? Obes Surg. 2020;30:3685–94.CrossRefPubMed Pizza F, Lucido FS, D’Antonio D, et al. Biliopancreatic limb length in one anastomosis gastric bypass: which is the best? Obes Surg. 2020;30:3685–94.CrossRefPubMed
18.
Zurück zum Zitat Sam MA, Hussain A, Pegler ME, et al. Effect of one anastomosis gastric bypass on liver function tests: a comparison between 150 cm and 200 cm biliopancreatic limbs. J Minim Access Surg. 2022;18:38.CrossRef Sam MA, Hussain A, Pegler ME, et al. Effect of one anastomosis gastric bypass on liver function tests: a comparison between 150 cm and 200 cm biliopancreatic limbs. J Minim Access Surg. 2022;18:38.CrossRef
19.
Zurück zum Zitat Jedamzik J, Eilenberg M, Felsenreich DM, et al. Impact of limb length on nutritional status in one-anastomosis gastric bypass: 3-year results. Surg Obes Relat Dis. 2020;16:476–84.CrossRefPubMed Jedamzik J, Eilenberg M, Felsenreich DM, et al. Impact of limb length on nutritional status in one-anastomosis gastric bypass: 3-year results. Surg Obes Relat Dis. 2020;16:476–84.CrossRefPubMed
20.
Zurück zum Zitat Bertrand T, Rives-Lange C, Jannot AS, et al. 150-cm versus 200-cm biliopancreatic limb one-anastomosis gastric bypass: propensity score-matched analysis. Obes Surg. 2022;32(9):2839–45.CrossRefPubMed Bertrand T, Rives-Lange C, Jannot AS, et al. 150-cm versus 200-cm biliopancreatic limb one-anastomosis gastric bypass: propensity score-matched analysis. Obes Surg. 2022;32(9):2839–45.CrossRefPubMed
21.
Zurück zum Zitat Grönroos S, Helmiö M, Juuti A, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss and quality of life at 7 years in patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA Surgery. 2021;156:137–46.CrossRefPubMed Grönroos S, Helmiö M, Juuti A, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss and quality of life at 7 years in patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA Surgery. 2021;156:137–46.CrossRefPubMed
22.
Zurück zum Zitat Ramos AC, Chevallier J-M, Mahawar K, et al. IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) consensus conference statement on one-anastomosis gastric bypass (OAGB-MGB): results of a modified Delphi study. Obes surg. 2020;30:1625–34.CrossRefPubMed Ramos AC, Chevallier J-M, Mahawar K, et al. IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) consensus conference statement on one-anastomosis gastric bypass (OAGB-MGB): results of a modified Delphi study. Obes surg. 2020;30:1625–34.CrossRefPubMed
23.
Zurück zum Zitat Smelt HJM, Van Rijn S, Pouwels S, et al. The influence of different alimentary and biliopancreatic limb lengths in gastric bypass patients. Obes Surg. 2021;31(2):481–9.CrossRefPubMed Smelt HJM, Van Rijn S, Pouwels S, et al. The influence of different alimentary and biliopancreatic limb lengths in gastric bypass patients. Obes Surg. 2021;31(2):481–9.CrossRefPubMed
24.
Zurück zum Zitat Mahawar KK, Himpens J, Shikora SA, et al. The first consensus statement on one anastomosis/mini gastric bypass (OAGB/MGB) using a modified Delphi approach. Obes Surg. 2018;28(2):303–12.CrossRefPubMed Mahawar KK, Himpens J, Shikora SA, et al. The first consensus statement on one anastomosis/mini gastric bypass (OAGB/MGB) using a modified Delphi approach. Obes Surg. 2018;28(2):303–12.CrossRefPubMed
25.
Zurück zum Zitat De Luca M, Tie T, Ooi G, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)-IFSO position statement. Obes Surg. 2018;28:1188–206.CrossRef De Luca M, Tie T, Ooi G, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)-IFSO position statement. Obes Surg. 2018;28:1188–206.CrossRef
26.
Zurück zum Zitat Parikh M, Eisenberg D, Johnson J, et al. American Society for Metabolic and Bariatric Surgery review of the literature on one-anastomosis gastric bypass. Surg Obes Relat Dis. 2018;14:1088–92.CrossRefPubMed Parikh M, Eisenberg D, Johnson J, et al. American Society for Metabolic and Bariatric Surgery review of the literature on one-anastomosis gastric bypass. Surg Obes Relat Dis. 2018;14:1088–92.CrossRefPubMed
27.
Zurück zum Zitat Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80.CrossRefPubMed Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80.CrossRefPubMed
28.
Zurück zum Zitat Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25:951–8.CrossRefPubMed Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25:951–8.CrossRefPubMed
29.
Zurück zum Zitat Noun R, Riachi E, Zeidan S, et al. Mini-gastric bypass by mini-laparotomy: a cost-effective alternative in the laparoscopic era. Obes Surg. 2007;17:1482–6.CrossRefPubMed Noun R, Riachi E, Zeidan S, et al. Mini-gastric bypass by mini-laparotomy: a cost-effective alternative in the laparoscopic era. Obes Surg. 2007;17:1482–6.CrossRefPubMed
30.
Zurück zum Zitat Mahawar KK. A biliopancreatic limb of >150 cm with OAGB/MGB is ill-advised. Obes Surg. 2017;27:2164–5.CrossRefPubMed Mahawar KK. A biliopancreatic limb of >150 cm with OAGB/MGB is ill-advised. Obes Surg. 2017;27:2164–5.CrossRefPubMed
31.
Zurück zum Zitat Ahuja A, Tantia O, Goyal G, et al. MGB-OAGB: effect of biliopancreatic limb length on nutritional deficiency, weight loss, and comorbidity resolution. Obes Surg. 2018;28(11):3439–45.CrossRefPubMed Ahuja A, Tantia O, Goyal G, et al. MGB-OAGB: effect of biliopancreatic limb length on nutritional deficiency, weight loss, and comorbidity resolution. Obes Surg. 2018;28(11):3439–45.CrossRefPubMed
32.
Zurück zum Zitat Neuberg M, Blanchet MC, Gignoux B, et al. Long-term outcomes after one-anastomosis gastric bypass (OAGB) in morbidly obese patients. Obes Surg. 2020;30(4):1379–84.CrossRefPubMed Neuberg M, Blanchet MC, Gignoux B, et al. Long-term outcomes after one-anastomosis gastric bypass (OAGB) in morbidly obese patients. Obes Surg. 2020;30(4):1379–84.CrossRefPubMed
33.
Zurück zum Zitat Tasdighi E, Barzin M, Mahawar KK, et al. Effect of biliopancreatic limb length on weight loss, postoperative complications, and remission of comorbidities in one anastomosis gastric bypass: a systematic review and meta-analysis. Obes Surg. 2022;32(3):892–903.CrossRefPubMed Tasdighi E, Barzin M, Mahawar KK, et al. Effect of biliopancreatic limb length on weight loss, postoperative complications, and remission of comorbidities in one anastomosis gastric bypass: a systematic review and meta-analysis. Obes Surg. 2022;32(3):892–903.CrossRefPubMed
34.
Zurück zum Zitat Ibrahim MY, Elshennawy AS, Wassef ATS, et al. One anastomosis gastric bypass versus long biliopancreatic limb Roux-en-Y gastric bypass. Obes Surg. 2022;32:779–85.CrossRefPubMedPubMedCentral Ibrahim MY, Elshennawy AS, Wassef ATS, et al. One anastomosis gastric bypass versus long biliopancreatic limb Roux-en-Y gastric bypass. Obes Surg. 2022;32:779–85.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Magouliotis DE, Tasiopoulou VS, Svokos AA, et al. One-anastomosis gastric bypass versus sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis. Obes Surg. 2017;27:2479–87.CrossRefPubMed Magouliotis DE, Tasiopoulou VS, Svokos AA, et al. One-anastomosis gastric bypass versus sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis. Obes Surg. 2017;27:2479–87.CrossRefPubMed
36.
Zurück zum Zitat Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: a meta-analysis. Clin Obes. 2018;8:159–69.CrossRefPubMed Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: a meta-analysis. Clin Obes. 2018;8:159–69.CrossRefPubMed
37.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.CrossRefPubMed Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.CrossRefPubMed
38.
Zurück zum Zitat Mahawar KK, Carr WRJ, Balupuri S, et al. Controversy surrounding ‘mini’ gastric bypass. Obes Surg. 2014;24:324–33.CrossRef Mahawar KK, Carr WRJ, Balupuri S, et al. Controversy surrounding ‘mini’ gastric bypass. Obes Surg. 2014;24:324–33.CrossRef
39.
Zurück zum Zitat Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393(10178):1299–309.CrossRef Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393(10178):1299–309.CrossRef
40.
Zurück zum Zitat Carbajo MA, Luque-de-León E, Jiménez JM, et al. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. 2017;27(5):1153–67.CrossRefPubMed Carbajo MA, Luque-de-León E, Jiménez JM, et al. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. 2017;27(5):1153–67.CrossRefPubMed
Metadaten
Titel
One Anastomosis Gastric Bypass (OAGB) with a 150-cm Biliopancreatic Limb (BPL) Versus a 200-cm BPL, a Systematic Review and Meta-analysis
verfasst von
Mohamed AbdAlla Salman
Ahmed Salman
Mohamed Moustafa Assal
Mohammed Elsherbiney
Mohamed Tourky
Ahmed Elewa
Adel Mohamed Khalaf
Mohamed A. Gadallah
Mahmoud Gebril
Sadaf Khalid
Hossam Shaaban
Aboalgasim Alamin Mohammed
Mohamed Hosny Abdo Osman
Haitham Hassan
Publikationsdatum
06.04.2023
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 6/2023
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-023-06556-9

Weitere Artikel der Ausgabe 6/2023

Obesity Surgery 6/2023 Zur Ausgabe

Chirurginnen nehmen sich Zwischenfälle im OP besonders zu Herzen

05.06.2024 Allgemeine Chirurgie Nachrichten

Selbstverschuldete Fehler oder unerwartete Komplikationen machen jungen Chirurginnen und Operateuren mit Migrationshintergrund offenbar besonders zu schaffen. Benötigt werden routinemäßige Programme zum Umgang mit Zwischenfällen im OP.

Schützt auch die medikamentöse Gewichtsreduktion vor Krebs?

03.06.2024 ASCO 2024 Kongressbericht

Offenbar muss es nicht immer die bariatrische Chirurgie sein, wenn es darum geht, durch deutlichen Gewichtsverlust auch das Krebsrisiko günstig zu beeinflussen. Eine große Kohortenanalyse zur Behandlung mit GLP-1-Agonisten wurde dazu auf der ASCO-Tagung vorgestellt.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.